Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain
Abstract Background Aminoglycosides such as amikacin and kanamycin are effective injectable second-line drugs for treatment of multidrug-resistant tuberculosis. Molecular mechanisms underlying aminoglycoside resistance are not well understood. We have previously identified the amikacin- and kanamyci...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2018-07-01
|
| Series: | Annals of Clinical Microbiology and Antimicrobials |
| Assuntos: | |
| Acceso en liña: | http://link.springer.com/article/10.1186/s12941-018-0285-6 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|